SNW(SH:600628)2025-01-16 09:46Financial Performance Expectations - The company expects a net profit attributable to shareholders for 2024 to increase by 35.84 million to 50.84 million CNY, representing a year-on-year growth of 113% to 161%[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to rise by 19.81 million to 27.81 million CNY, indicating a year-on-year increase of 122% to 172%[3]. - The estimated net profit for 2024 is between 67.5 million to 82.5 million CNY, compared to 31.66 million CNY in the previous year[3][5]. - The net profit after deducting non-recurring gains and losses for 2024 is expected to be between 36 million to 44 million CNY, up from 16.19 million CNY last year[3][5]. Growth Drivers - The company's retail, pharmaceutical sales, and hotel services sectors have shown diversified growth due to multiple consumer stimulus policies[8]. - Government subsidies have increased compared to last year, contributing positively to non-operating gains[9]. Audit and Forecast Validity - The company has not received a special report from auditors regarding the appropriateness and prudence of the earnings forecast[4][10]. - The forecast data is preliminary and subject to change upon the release of the audited annual report for 2024[11].